UBC The current public health crisis has accelerated collecting data in a decentralized manner. The biopharmacuetical industry had already begun to harness transformative approaches to collecting data in novel ways, including from remote sources across a wide range of settings and using diverse modalities. The pandemic has proven to be a catalyst for an even more comprehensive set of solutions to collect critical evidence beyond the walls of the traditional study setting. Regulatory agencies propelled this trend by releasing new guidances.
Leave a Comment